Jefferies Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-31,000
Closed -$1.25M 1696
2021
Q4
$1.25M Buy
+31,000
New +$1.16M 0.01% 938
2019
Q3
Sell
-93,800
Closed -$1.61M 2821
2019
Q2
$1.61M Buy
+93,800
New +$1.51M 0.01% 1040
2017
Q4
Sell
-17,200
Closed -$299K 2607
2017
Q3
$299K Buy
+17,200
New +$233K ﹤0.01% 1882
2014
Q1
Sell
-88,400
Closed -$1.32M 2177
2013
Q4
$1.32M Buy
+88,400
New +$1.14M 0.01% 715

Other funds holding HALO

Jefferies Group's HALO Position: Q2 2022 in Review

Jefferies Group sold out of Halozyme (HALO) in Q2 2022, closing a stake of 14,797 shares — an estimated $590K sold.

Jefferies Group first reported a position in HALO in Q3 2013 and held it in 10 quarters. The position peaked at $816K in Q2 2019. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Jefferies Group reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 14,797 Halozyme shares in Q2 2022, an estimated $590K.
  • Jefferies Group first reported a position in Halozyme in Q3 2013 and held it in 10 quarters.
  • Jefferies Group's Halozyme position peaked at $816K in Q2 2019.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.